COMET BIOTECH AS
Operating
Utvikle og kommersialisere tjenester og teknologi innen
gentoksikologisk testing.
Foreta prøver for gentoksisitet av kjemiske substanser,
konsulentbistand innen gentoksisitet, forskning innen gentoksisitet.
Links
Organization
- CEO
- Chairman of the board
- GC
- Years since formation
- 16 years
- since Nov 16, 2010
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2025
- 25,000
- NOK
- Annual total result 2025
- 2,032
- NOK
- Total equity 2025
- 167,743
- NOK
Last update: May 19, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | 25.39 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
GC | Chairman | - |
SS | Board Member | 4.13 % indirectly |
GB 1947 | Board Member | 10.43 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
OC | - | 49.61 % indirectly |
| Managing Director/CEO | 25.39 % indirectly | |
GB 1947 | Board Member | 10.43 % indirectly |
JM | - | 7.09 % indirectly |
SS | Board Member | 4.13 % indirectly |
AA | - | 3.35 % indirectly |
Last update: Dec 16, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 100,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 2,655,397Operating profit 2025: NOK 31,195Employees: 5
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 25,000 | 49,000 | 177,980 | 283,060 | 300,000 |
Annual Total Result | 2,032 | 15,971 | 30,428 | -7,181 | -6,676 |
Total assets | 179,698 | 234,936 | 271,545 | 370,759 | 1,259,463 |
Total liabilities | 11,955 | 69,225 | 121,806 | 251,448 | 1,132,971 |
Total equity | 167,743 | 165,710 | 149,739 | 119,311 | 126,492 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 25,000 | 49,000 | 177,980 | 283,060 | 300,000 |
Total operating costs | 22,958 | 32,979 | 147,412 | 290,171 | 306,676 |
Operating result | 2,042 | 16,021 | 30,568 | -7,111 | -6,676 |
Financial income/costs | -9 | -50 | -140 | -70 | 0 |
Profit before tax | 2,032 | 15,971 | 30,428 | -7,181 | -6,676 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | 2,032 | 15,971 | 30,428 | -7,181 | -6,676 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 | 0 |
Total current assets | 179,698 | 234,936 | 271,545 | 370,759 | 1,259,463 |
Total assets | 179,698 | 234,936 | 271,545 | 370,759 | 1,259,463 |
Short term debt | 11,955 | 69,225 | 121,806 | 251,448 | 1,132,971 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 11,955 | 69,225 | 121,806 | 251,448 | 1,132,971 |
Contributed capital | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 |
Retained earnings | -32,257 | -34,290 | -50,261 | -80,689 | -73,508 |
Total equity | 167,743 | 165,710 | 149,739 | 119,311 | 126,492 |
Total equity and liabilities | 179,698 | 234,936 | 271,545 | 370,759 | 1,259,463 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises